Skip Navigation

Cardiovascular Research 2004 63(2):264-272; doi:10.1016/j.cardiores.2004.04.001
© 2004 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Kiarash, A.
Right arrow Articles by Cala, S. E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kiarash, A.
Right arrow Articles by Cala, S. E
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2004, European Society of Cardiology

Defective glycosylation of calsequestrin in heart failure

Arash Kiarasha, Carmen E Kellya, Brett S Phinneyb, Héctor H Valdiviac, Judith Abramsd and Steven E Cala*,a

aProgram in Molecular and Cellular Cardiology, Cardiology Research Division, Department of Medicine, Wayne State University, Elliman Building, Room 1107, 421 E. Canfield Avenue, Detroit, MI 48201, USA
bMichigan Proteome Consortium, Department of Biochemistry, 3B Biochemistry, Wilson Road, East Lansing, MI 48824, USA
cDepartment of Physiology, University of Wisconsin-Madison, 1300 University Ave., Madison, WI 53706, USA
dBarbara Ann Karmanos Cancer Institute, Wayne State University, 716 Harper Professional Office Building, Detroit, MI 48201, USA

* Corresponding author. Tel.: +1-313-5778734; fax: +1-313-5778615. Email address: s.cala{at}wayne.edu

Objective: Levels of Ca2+ regulatory proteins have been extensively analyzed in cardiomyopathies as possible indices of change in sarcoplasmic reticulum (SR) structure and function. Measures of calsequestrin (CSQ), however, a critical protein component of the Ca2+ release complex in junctional sarcoplasmic reticulum, have provided little or no evidence of underlying dysfunction. We previously reported that calsequestrin isolated from heart tissue exists in a variety of glycoforms and phosphoforms reflecting mannose trimming of N-linked glycans and phosphorylation and dephosphorylation on protein kinase CK2-sensitive sites. Methods: Here, we tested whether the distribution of molecular forms changes in heart failure (HF) reflecting possible remodeling of diseased tissue. Canine hearts were paced (220 beats/min) for 6–8 weeks to induce heart failure. Calsequestrin was purified from heart failure and sham-operated (control) treated canine ventricles and analyzed by electrospray mass spectrometry. Results: The results showed striking changes in the mass distribution of calsequestrin molecules present in tissue from heart failure (five animals) compared with control (five animals). In heart failure, calsequestrin contained glycan structures that were uncharacteristic of normal junctional sarcoplasmic reticulum, consistent with altered metabolism or altered trafficking through secretory compartments. Glycoforms containing Man8,9, expected for a phenotype less muscle-like, were more than doubled in heart failure hearts, and molecules were also phosphorylated to a higher level. Conclusions: These data reveal in tachycardia-induced heart failure a new and potentially important change in the mannose content of calsequestrin glycans, perhaps indicative of defective junctional SR trafficking and Ca2+ release complex assembly.

KEYWORDS Calsequestrin; Mass spectrometry; Heart failure; Phosphorylation; CK2; SR

Time for primary review 17 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.